These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12768435)

  • 21. Mutations of Bruton's tyrosine kinase gene in Brazilian patients with X-linked agammaglobulinemia.
    Ramalho VD; Oliveira Júnior EB; Tani SM; Roxo Júnior P; Vilela MM
    Braz J Med Biol Res; 2010 Sep; 43(9):910-3. PubMed ID: 20721470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis.
    Mattsson PT; Lappalainen I; Bäckesjö CM; Brockmann E; Laurén S; Vihinen M; Smith CI
    J Immunol; 2000 Apr; 164(8):4170-7. PubMed ID: 10754312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
    Speletas M; Kanariou M; Kanakoudi-Tsakalidou F; Papadopoulou-Alataki E; Arvanitidis K; Pardali E; Constantopoulos A; Kartalis G; Vihinen M; Sideras P; Ritis K
    Scand J Immunol; 2001 Sep; 54(3):321-7. PubMed ID: 11555397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of mutations of Bruton's tyrosine kinase gene (BTK) in Brazilian patients with X-linked agammaglobulinemia.
    Tani SM; Wang Y; Kanegane H; Futatani T; Pinto J; Vilela MM; Miyawaki T
    Hum Mutat; 2002 Sep; 20(3):235-6. PubMed ID: 12204007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of Bruton's tyrosine kinase mutations in Mexican patients with X-linked agammaglobulinemia.
    Lopez-Herrera G; Berron-Ruiz L; Mogica-Martinez D; Espinosa-Rosales F; Santos-Argumedo L
    Mol Immunol; 2008 Feb; 45(4):1094-8. PubMed ID: 17765309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
    de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
    Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of nine novel mutations in the Bruton's tyrosine kinase gene in X-linked agammaglobulinaemia patients.
    Orlandi P; Ritis K; Moschese V; Angelini F; Arvanitidis K; Speletas M; Sideras P; Plebani A; Rossi P
    Hum Mutat; 2000 Jan; 15(1):117. PubMed ID: 10612838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel deletion mutation and structural abnormality in the Bruton's tyrosine kinase gene identified in a Chinese patient with X-linked agammaglobulinemia.
    Wang S; Lu Y; Li H; Wang Z; Mo X; Chai Z; Han J
    Clin Lab; 2014; 60(5):859-62. PubMed ID: 24839832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia.
    Schuster V; Seidenspinner S; Kreth HW
    Am J Med Genet; 1996 May; 63(1):318-22. PubMed ID: 8723128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mutation analysis and prenatal diagnosis in families of X-linked agammaglobulinemia caused by BTK gene mutation].
    Kong X; Mo G; Liu N; Tian P; Chen M
    Zhonghua Yi Xue Za Zhi; 2014 May; 94(18):1405-8. PubMed ID: 25142992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of Bruton's tyrosine kinase gene in Spain.
    Rodríguez MC; Granados EL; Cerdán AF; Casariego GF
    Hum Mutat; 2001; 18(1):84. PubMed ID: 11438999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection.
    Futatani T; Miyawaki T; Tsukada S; Hashimoto S; Kunikata T; Arai S; Kurimoto M; Niida Y; Matsuoka H; Sakiyama Y; Iwata T; Tsuchiya S; Tatsuzawa O; Yoshizaki K; Kishimoto T
    Blood; 1998 Jan; 91(2):595-602. PubMed ID: 9427714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA).
    Jin H; Webster AD; Vihinen M; Sideras P; Vorechovsky I; Hammarstróm L; Bernatowska-Matuszkiewicz E; Smith CI; Bobrow M; Vetrie D
    Hum Mol Genet; 1995 Apr; 4(4):693-700. PubMed ID: 7633420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
    Gaspar HB; Lester T; Levinsky RJ; Kinnon C
    Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BTKbase, mutation database for X-linked agammaglobulinemia (XLA).
    Vihinen M; Belohradsky BH; Haire RN; Holinski-Feder E; Kwan SP; Lappalainen I; Lehväslaiho H; Lester T; Meindl A; Ochs HD; Ollila J; Vorechovsky I; Weiss M; Smith CI
    Nucleic Acids Res; 1997 Jan; 25(1):166-71. PubMed ID: 9016530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic analysis of contiguous X-chromosome deletion syndrome encompassing the BTK and TIMM8A genes.
    Arai T; Zhao M; Kanegane H; van Zelm MC; Futatani T; Yamada M; Ariga T; Ochs HD; Miyawaki T; Oh-ishi T
    J Hum Genet; 2011 Aug; 56(8):577-82. PubMed ID: 21753765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unique mutations of Bruton's tyrosine kinase in fourteen unrelated X-linked agammaglobulinemia families.
    Zhu Q; Zhang M; Winkelstein J; Chen SH; Ochs HD
    Hum Mol Genet; 1994 Oct; 3(10):1899-900. PubMed ID: 7849721
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical features and mutational analysis of X-linked agammaglobulinemia patients in Malaysia.
    Chear CT; Ismail IH; Chan KC; Noh LM; Kassim A; Latiff AHA; Gill SS; Ramly NH; Tan KK; Sundaraj C; Choo CM; Mohamed SAS; Baharin MF; Zamri AS; Yahya SNHS; Mohamad SB; Ripen AM
    Front Immunol; 2023; 14():1252765. PubMed ID: 37809070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Bruton's tyrosine kinase in B lymphoblastoid cell lines from X-linked agammaglobulinaemia patients.
    De Weers M; Dingjan GM; Brouns GS; Kraakman ME; Mensink RG; Lovering RC; Schuurman RK; Borst J; Hendriks RW
    Clin Exp Immunol; 1997 Feb; 107(2):235-40. PubMed ID: 9030858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia.
    Yeh YH; Hsieh MY; Lee WI; Huang JL; Chen LC; Yeh KW; Ou LS; Yao TC; Wu CY; Lin SJ
    Front Immunol; 2020; 11():2001. PubMed ID: 33013854
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.